Fiancé's Jasmine Pineda confirms she's expecting a baby in a video she shared on Instagram, and Gino is not the father. The ...

Limited (NYSE: WNS), a digital-led business transformation and services partner, today announced that it has been recognized as a ‘Leader’ across multiple service lines in ISG’s 2024 Provider Lens™ ...

Globe Life Inc.’s GL fourth-quarter 2024 net operating income of $3.14 per share beat the Zacks Consensus Estimate by 1.3%. The bottom line improved 12% year over year, primarily driven by ...

Could investing in an airline stock set you up for life? It's an interesting question ... and why is United Airlines (NASDAQ: UAL) worth considering? Here's the lowdown. The International Air ...

Sumitomo Life Insurance Co. lowered its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 7.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities ...

GLOBE LIFE ($GL) posted quarterly earnings results on Wednesday, February 5th. The company reported earnings of $3.14 per share, missing estimates of $3.22 by $0.08 ...

Globe Life (GL) came out with quarterly earnings of $3.14 per share, beating the Zacks Consensus Estimate of $3.10 per share. This compares to earnings of $2.80 per share a year ago. These figures ...

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical ... at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Wednesday, February ...

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing ...

Feb. 4, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical ... 2025 at the Oppenheimer 35th Annual Healthcare Life Sciences Conference. A webcast of the presentation will ...

"This award for digital transformation excellence is a testament ... of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the ...

Wave Life Sciences Ltd. (NASDAQ:WVE) shareholders might be concerned after seeing the share price drop 14% in the last quarter. But that doesn't displace its brilliant performance over three years.